Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease-Reference-Cited by-同舟云学术

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

Published:2009-02 Issue:2 Volume:30 Page:165-173
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Hansson Oskar,Buchhave Peder,Zetterberg Henrik,Blennow Kaj,Minthon Lennart,Warkentin Siegbert

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference37 articles.

1. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment;Arnaiz;Neuroreport,2001

2. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. American Psychiatric Association, Arlington, VA, USA.

3. Alzheimer's disease;Blennow;Lancet,2006

4. CSF markers for incipient Alzheimer's disease;Blennow;Lancet Neurol.,2003

5. Longitudinal stability of CSF biomarkers in Alzheimer's disease;Blennow;Neurosci. Lett.,2007

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis;Alzheimer's Research & Therapy;2024-04-12

2. An overview on Alzheimer’s disease, diagnosis and treatment approach;International Journal of Allied Medical Sciences and Clinical Research;2023-10-09

3. How far is the goal of applying β-amyloid in cerebrospinal fluid for clinical diagnosis of Alzheimer’s disease with standardization of measurements?;Clinical Biochemistry;2023-02

4. Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis;Frontiers in Aging Neuroscience;2022-04-07

5. Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study;Frontiers in Aging Neuroscience;2021-01-15